The submission of medical cannabis from the Congress of Deputies approved the regulation of marijuana for therapeutic purposes on June 21, 2022. However, such a proposal needs ratification by the Health Commission, which will take place on June 28, 2022, after which the Spanish Agency of Medicines (AEMPS) will have 6 months to perform the necessary changes in order to turn these recommendations into viable options. Hopefully, medical cannabis will be ready for distribution by the end of the year.

The AEMPS will still have to define the necessary mechanisms to prescribe, provide and sell such products and to decide which patients will have access to it.

Who will be able to access medical cannabis?

The main objective of this proposal is to widen its use to cancer and endometriosis sufferers. This way, Spain will join a total of 40 territories, 10 of them in the EU, where cannabis is legal for therapeutic uses. To buy it, patients will need a medical prescription and it will be aimed at sufferers of the following conditions:

  • Multiple sclerosis
  • Certain types of epilepsy
  • Nausea and vomits caused by chemotherapy
  • Endometriosis
  • Cancer pain
  • Chronic pain (including neuropathic pain)

However, the Congress submission doesn’t close the doors to other types of patients. This list can be extended if clinical trials offer positive results.

Where will medical marijuana be available in Spain?

Pharmacies will be in charge of dispensing the formula. The new law recommends only hospital pharmacies, but community pharmacies will need to meet certain requirements before distributing it. These products will need to be prescribed by health professionals, preferably specialists.

Probably, by the end of the year, there should be a report stating the different options, such as the patients that can access these services and the amount of dispensed product for each case. The idea would be to have a registry of the patients that can benefit from these products.

medical cannabis

What will be the dispensation format of medical marijuana?

At the moment, recommendations opt for all those formulas or standardized extracts that as of now don’t have selling authorization. According to the sub-commission, these ready made products already comply with certain standards and a defined concrete composition, such as CBD oil, which means that their dosage is easier, more stable and comfortable to handle.

The report also mentions the possibility for pharmacies to elaborate their own formulas using certain extracts or standardized cannabis products.

At this time, only two medicines have been accepted by regulatory authorities as they’ve passed clinical trials. One of them is Sativex, used to treat multiple sclerosis, and Epidyolex, suitable to treat different types of epilepsy.

Recreational use will have to wait

Although the focus is on medical cannabis, different parliament groups wanted to legalize all cannabis consumption forms. Unfortunately, for the moment, that door is closed, but they are trying to create a sub-commission to study this option.

As a matter of fact, the approved document specifically states that the population should not mistake medical use as invocation to general use. For the moment, any possibility related to self-consumption or self-cultivation is out of the question.

medical cannabis therapy

Benefits of regulating the use of medical cannabis

As an estimation, the regulation of medical cannabis in Spain could benefit around 200,000 people, who would improve their quality of life. On the other hand, this regulation will also avoid other forms of cannabis consumption with less controls; which could affect the quality of life and the safety of people that use it for medical reasons.

Regulating therapeutic cannabis will bring relief to plenty of patients suffering conditions that are difficult to treat, who will now find comfort in an easier and more controlled way. Plenty of studies prove that marijuana relieves the following symptoms:

  • Analgesic: by relieving pain.
  • Anti-inflammatory: reducing neuronal pain.
  • Immune-modulator: It modulates the immune system.
  • Regulates muscle tone: It relieves muscle spasms and trembling limbs.
  • Anxiolytic, antidepressant and relaxant.
  • Neuroprotector: Its antioxidant properties improve memory and attention.

This approved report is the result of eight months of hard work and analysis, where results of other countries have been studied by experts in the matter. Medical cannabis is already legal in other countries, such as Germany, Portugal or Italy and Spain is only one step away. For the moment, we’ll have to wait until the end of 2022 to see the results of this approval.

Click to rate this post!
[Total: 0 Average: 0]

Erik Collado

With more than 10 years of background in the cannabis sector, his experience and knowledge are the base of GB The Green Brand’s success

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Leave a Reply

Your email address will not be published. Required fields are marked *